References
Abdelnabi M, Ahmed A, Almaghraby A, Saleh Y, Badran H. Ivabradine and AF: coincidence, correlation or a new treatment? Arrhythm Electrophysiol Rev. 2020;8(4):300–3.
Verrier RL, Bonatti R, Silva AF, Batatinha JA, Nearing BD, Liu G, Rajamani S, Zeng D, Belardinelli L. If inhibition in the atrioventricular node by ivabradine causes rate-dependent slowing of conduction and reduces ventricular rate during atrial fibrillation. Heart Rhythm. 2014;11(12):2288–96.
Wongcharoen W, Ruttanaphol A, Gunaparn S, Phrommintikul A. Ivabradine reduced ventricular rate in patients with non-paroxysmal atrial fibrillation. Int J Cardiol. 2016;224:252–5.
Funding
Li Shu Fan Fellowship for Internal Medicine 2021/22.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
Approved by the Institutional Review Board, University of Hong Kong.
Informed consent
N/A
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Chan, YH., Hai, JJ., Wong, CK. et al. Ventricular rate control with ivabradine in patients with permanent atrial fibrillation. J Interv Card Electrophysiol 65, 597–599 (2022). https://doi.org/10.1007/s10840-022-01344-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-022-01344-4